Sarepta Names Severino CEO in Planned Succession
Sarepta Therapeutics appointed Michael Severino, M.D., chief executive officer and a director, effective July 28, 2026. He succeeds Doug Ingram, whose retirement plan was disclosed on February 25; Ingram will remain an advisor through…
